Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery
Key facts
- Who runs it
- Istanbul University - Cerrahpasa
- Where
- Türkiye2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 63 people enrolled
- Started
- 14 Jan 2026
- Ended
- 16 Jul 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Target Controlled Infusion
- Total Intravenous Anesthesia(TIVA)
- Record updated
- 9 September 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adult patients aged 18 to 60 years
- Scheduled for elective supratentorial surgery under general anesthesia
- American Society of Anesthesiologists (ASA) physical status I or II
- Planned total intravenous anesthesia with propofol and remifentanil
- Ability to provide written informed consent
Who cannot take part
- Emergency surgery
- Intraoperative deviation from the study protocol, including changes in surgical or anesthetic technique or occurrence of major intraoperative complications
- Inability to communicate effectively (e.g., non-Turkish speaking or hearing impairment)
- Preoperative risk factors for delirium, including substance abuse, use of neuropsychiatric medications, preoperative hemoglobin level < 8 g/dL, malnutrition, or electrolyte or thyroid hormone abnormalities
- Refusal or inability to provide written informed consent
- American Society of Anesthesiologists (ASA) physical status III or higher
- Pregnancy
- Presence of brain herniation
- Anticipated or documented difficult airway
- Contraindications to propofol or remifentanil
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate the effect of target-controlled infusion using the Eleveld pharmacokinetic model compared with manually controlled total intravenous anesthesia on the incidence of postoperative delirium in patients undergoing supratentorial surgery. Propofol and remifentanil are administered using either target-controlled or manual infusion techniques according to the study protocol. Secondary objectives include comparisons of intraoperative anesthetic consumption, hemodynamic responses, recovery profiles, postoperative pain, and postoperative nausea and vomiting between the two anesthesia strategies. The study seeks to evaluate whether target-controlled infusion provides improved anesthetic management and postoperative outcomes compared with manual total intravenous anesthesia.
The 2 groups in the trial
- Manual Total Intravenous AnesthesiaTreatment being tested
Participants receive manually controlled total intravenous anesthesia using propofol and remifentanil, with dosing adjusted by the anesthesiologist based on clinical parameters and bispectral index monitoring.
Treatment: Total Intravenous Anesthesia(TIVA)
- Target-Controlled Infusion (TCI)Treatment being tested
Participants receive target-controlled infusion of propofol and remifentanil using the Eleveld pharmacokinetic model, with effect-site targeting throughout the surgical procedure.
Treatment: Target Controlled Infusion
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparison of Target-Controlled Infusion Using the Eleveld Model and Manual Total Intravenous Anesthesia on Intraoperative Anesthetic Consumption and Postoperative Pain and Delirium in Supratentorial Surgery
- Record updated
- 9 September 2026